NCAM1 and large cell neuroendocrine carcinoma: Gynecologic LCNEC must therefore be assessed via immunohistochemical analysis, as these tumors exhibit a positive immune response to at least one neuroendocrine marker such as synaptophysin, chromogranin A, neuron-specific alkene-positive immunostaining for alcoholase or CD56, or p63 (38).